Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

13

Portfolio Exits

4

About BTG Ventures

BTG Ventures is an investment arm of BTG Plc which makes seed and early stage investments. The company typically invests in novel technologies in life sciences. Investment locations typically occur in Europe and North America, concentrating in the UK and the Mid-Atlantic areas of North America. The firm is headquartered in London with an office in Pennsylvania, USA.

BTG Ventures Headquarter Location

10 Fleet Place Limeburner Lane

London, England, EC4M 7SB,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BTG Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find BTG Ventures in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

BTG Ventures Investments

13 Investments

BTG Ventures has made 13 investments. Their latest investment was in Avera Pharmaceuticals as part of their Unattributed VC - II on February 2, 2008.

CBI Logo

BTG Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/11/2008

Unattributed VC - II

Avera Pharmaceuticals

$9M

No

1/17/2008

Unattributed VC

Senexis

$6M

Yes

1

2/8/2007

Unattributed VC

Avera Pharmaceuticals

$6.65M

No

11/23/2006

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

4/6/2006

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/11/2008

1/17/2008

2/8/2007

11/23/2006

4/6/2006

Round

Unattributed VC - II

Unattributed VC

Unattributed VC

Unattributed VC - II

Series B

Company

Avera Pharmaceuticals

Senexis

Avera Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$9M

$6M

$6.65M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

BTG Ventures Portfolio Exits

4 Portfolio Exits

BTG Ventures has 4 portfolio exits. Their latest portfolio exit was Flow International on September 26, 2013.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/26/2013

Take Private

$991

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

9/26/2013

00/00/0000

00/00/0000

00/00/0000

Exit

Take Private

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.